Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

UCB teams up with charity to beat treatment-resistant epilepsy in $2.5m partnership

February 11, 2019 Research and Development, Sales and Marketing Epilepsy Society, UCB Pharma, epilepsy, pharma

Belgian firm UCB Pharma has announced a new partnership with the charity Epilepsy Society which will see the pair invest …
News

Dame Sally Davis to step down as England’s CMO to become Master of Trinity College, Cambridge

February 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Professor Dame Sally Davies is set to step down from her roles as England’s Chief Medical Officer and as the …
Appointment

Researchers develop new, more effective method for detection of HIV virus genomes

February 8, 2019 Medical Communications, Research and Development HIV, University of Texas, pharma

A team of researchers have devised a new way to accurately detect residual HIV in the body’s immune cells, allowing …
News
pat_smallcombe

Pat Smallcombe appointed chairman of J&J Consumer, EMEA

February 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Johnson & Johnson Consumer has appointed Pat Smallcombe to the position of Company Group Chairman, Europe, Middle East, Africa (EMEA). …
Appointment
shutterstock_3

FDA warns over breast implant cancer risk after nine deaths confirmed

February 8, 2019 Medical Communications, Research and Development Cancer, FDA, breast implants, pharma

The FDA has warned against the link between breast implants and anaplastic large cell lymphoma, noting that at least nine …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, Merck, Pfizer, falsified medicines, strike, top 10

The strike in Ireland featured twice in this week’s top 10 after Pfizer employees in County Cork lost a dispute …
News
donato_spota

Hansa Biopharma names Donato Spota as new CFO

February 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Swedish firm Hansa Biopharma has appointed Donato Spota as the company’s new Chief Financial Officer (CFO). Spota will succeed current …
Appointment
chimerix_headshots_140x140_michelle-138x138

Chimerix CEO M. Michelle Berrey to stand down as interim Office of Cheif Executive Officer is formed

February 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The North Carolina-based biopharmaceutical company Chimerex has announced that Dr M. Michelle Berrey has resigned from her role as President …
Appointment
shutterstock_360472550

Eisai and Purdue reveal positive Phase 3 data in insomnia

February 7, 2019 Research and Development Eisai, Purdue Pharma, insomnia, lemborexant, pharma

Partners Eisai and Purdue Pharma have lifted the curtain on Phase 3 clinical data on their jointly developed therapy lemborexant …
News

HIV drug holds hope for Alzheimer’s after significantly reducing inflammation in mice

February 7, 2019 Research and Development HIV, dementia, inflamation

Lamivudine, a generic drug for HIV, significantly reduces age-related inflammation and other signs of aging in mice, according to a …
News
shutterstock_273326141

NICE joins forces with Canadian peer to offer scientific advice to the pharma industry

February 6, 2019 Research and Development, Sales and Marketing CADTH, Canada, NICE, UK, pharma

NICE has announced a collaboration with its Canadian counterpart, the Canadian Agency for Drugs and Technology in Health (CADTH), with …
News

Sanofi’s Icaria combo extends progression-free survival in multiple myeloma at Phase 3

February 6, 2019 Research and Development Icaria, Sanofi, multiple myeloma, pharma

Sanofi has continued to make progress in the development of Icaria (isatuximab), with the company announcing that the therapy met …
News
genentech_web

Genentech to develop ‘highly active cytokine’ with Xancor in deal worth $300m

February 6, 2019 Research and Development Cancer, Genetech, IL-15 cytokine, Roche, Xancor, oncology

Roche’s Genentech unit has agreed to pay $120 million upfront as part of a research and licensing deal with California-based …
News
shirelabsus

Takeda ordered to pay Bayer $155.19 million over patent infringement

February 6, 2019 Research and Development Baxalta, Bayer, Nektar Therapeutics, Takeda, adynovate

A US court has ordered Takeda Pharmaceutical’s Baxalta unit to pay German firm Bayer AG $155.19 million for infringement of …
News
mr058666-web

GSK buys Merck KGaA’s cancer immunotherapy for $4.2 billion

February 6, 2019 Research and Development GSK, M7824, Merck, immunotherapy

British multinational GlaxoSmithKline has agreed to pay up to €3.7 billion ($4.2 billion) for the rights to Merck KGaA’s next …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026